Skip to content

FRONTLINE HEALTHCARE PARTNERS

FRONTLINE HEALTHCARE PARTNERS is a Series C+ and buyout fund in the US investing in healthcare-tech, value-added-healthcare-services and multi-site-healthcare.

Stages
Series C+, buyout
Sectors
healthcare-tech, value-added-healthcare-services, multi-site-healthcare
Invests in
US-wide
Actively investing
Yes
Founded
2020
Assets under management
$168M

Check size not disclosed

Thesis

Frontline Healthcare Partners (FHP) is a private equity firm founded in 2020 and based in Charleston, South Carolina. The firm specializes in investing in lower middle market, distributed healthcare businesses, with a focus on micro-cap companies in three core areas: Multi-Site Healthcare, Healthcare Technology, and Value-Added Healthcare Services. FHP's investment strategy involves partnering with founders and management teams, often through significant minority stake rollovers, and applying "White Coat" & "Blue Coat" principles to drive quality patient care and trust. Their inaugural fund, Frontline Healthcare Partners, L.P., closed at $125 million in December 2024, dedicated to control investments in micro-cap distributed healthcare businesses, typically with $1 to $5 million in EBITDA. The firm primarily invests in the United States and had approximately $168,147,525 in AUM as of March 30, 2026. They also leverage a network of Advisor Partners for specialized sector knowledge.

Common questions

Does FRONTLINE HEALTHCARE PARTNERS invest at the Series C+ stage?

Yes. FRONTLINE HEALTHCARE PARTNERS lists Series C+ and buyout among the stages it invests in.

Where does FRONTLINE HEALTHCARE PARTNERS invest?

FRONTLINE HEALTHCARE PARTNERS invests in the US.